Amanote Research
Register
Sign In
Thymidine Phosphorylase Expression in Tumour Cells and Tumour Response to Capecitabine Plus Docetaxel Chemotherapy in Non-Small Cell Lung Cancer
Journal of Clinical Pathology
- United Kingdom
doi 10.1136/jcp.2004.022764
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Forensic Medicine
Pathology
Date
June 1, 2005
Authors
J-Y Han
Publisher
BMJ
Related search
Different Patterns of Stromal and Cancer Cell Thymidine Phosphorylase Reactivity in Non-Small-Cell Lung Cancer: Impact on Tumour Neoangiogenesis and Survival
British Journal of Cancer
Cancer Research
Oncology
Interleukin-10-Regulated Tumour Tolerance in Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Overexpression of WDR79 in Non-Small Cell Lung Cancer Is Linked to Tumour Progression
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine Plus Docetaxel in Non-Small-Cell Lung Cancer Patients
PLoS ONE
Multidisciplinary
Platelet-Derived Endothelial Cell Growth Factor Expression Correlates With Tumour Angiogenesis and Prognosis in Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
The Clinical Utility of Circulating Tumour Cells in Patients With Small Cell Lung Cancer
Translational Lung Cancer Research
Oncology
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Clinical Response to Chemotherapy in Non-Small Cell Lung Carcinoma Patients
International Journal of Research in Medical Sciences
